The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus

Table 1

Clinical characteristics.

		Dulaglutide group ()	Glargine group ()
Sex (female%)	Baseline	6 (37.50%)	4 (44.44%)		1
History (years)	Baseline	8 (5, 14.5)	5(3, 11.5)	−1.08	0.293
Age (years)	Baseline	59.88 ± 8.17	65.44 ± 11.09	−1.438	0.164
Height (cm)	Baseline	165.13 ± 7.48	159.44 ± 6.21	1.93	0.066
Weight (kg)	Baseline	68.97 ± 10.13	62.56 ± 5.72	2.023	0.055
	52w	69.06 ± 9.85	64.67 ± 6.20	1.205	0.24
Body mass index (kg/m^2)	Baseline	25.22 ± 2.67	24.63 ± 2.12	0.57	0.574
	52w	25.26 ± 2.53	25.46 ± 2.30	−0.198	0.845
Systolic BP (mmHg)	Baseline	134.38 ± 13.93	133.67 ± 11.94	0.128	0.899
	52w	134.69 ± 16.91	135.44 ± 10.00	−0.122	0.904
Diastolic BP (mmHg)	Baseline	80.06 ± 8.65	77.44 ± 8.53	0.73	0.473
	52w	82.38 ± 8.98	77.89 ± 8.59	1.217	0.236
Heart rate (bpm)	Baseline	78.56 ± 7.20	73.33 ± 6.75	1.781	0.088
	52w	77.50 ± 6.76	75.44 ± 11.25	0.574	0.571
Corrected QT interval	Baseline	438.52 ± 27.42	431.90 ± 18.22	0.636	0.531
	52w	437.00 ± 26.59	427.44 ± 25.41	0.876	0.39

BP: blood pressure.